Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes

Oncotarget

Volumn 7, Issue 50, 2016, Pages 83669-83683

  Blomme, Arnaud ^a   Fahmy, Karim ^a   Peulen, Olivier ^a   Costanza, Brunella ^a   Fontaine, Marie ^a   Struman, Ingrid ^a   Baiwir, Dominique ^a   de Pauw, Edwin ^a   Thiry, Marc ^a   Bellahcène, Akeila ^a   Castronovo, Vincent ^a   Turtoi, Andrei ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Angiogenesis; Endothelial cells; Proteomics; Vesicle trafficking

Indexed keywords

CELL PROTEIN; MYOFERLIN; NUCLEIC ACID; REGULATOR PROTEIN; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; MEMBRANE PROTEIN; MUSCLE PROTEIN; MYOF PROTEIN, HUMAN;

ARTICLE; BREAST CANCER CELL LINE; CANCER CELL; CELL FUSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOLOGY; ENDOCYTOSIS; EXOSOME; HUMAN; HUMAN CELL; NUCLEIC ACID TRANSPORT; PANCREATIC CANCER CELL LINE; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; UMBILICAL VEIN ENDOTHELIAL CELL; VALIDATION PROCESS; ANGIOGENESIS; BREAST TUMOR; CELL MOTION; ELECTRON MICROSCOPY; FEMALE; GENETIC TRANSFECTION; GENETICS; MALE; MCF-7 CELL LINE; METABOLISM; PANCREAS TUMOR; PROCEDURES; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ULTRASTRUCTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; EXOSOMES; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MCF-7 CELLS; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; MUSCLE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PANCREATIC NEOPLASMS; PROTEIN INTERACTION MAPS; PROTEOMICS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 85004007208     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.13276     Document Type: Article

References (51)

1. Thery C, Zitvogel L and Amigorena S. Exosomes: composition, biogenesis and function. Nature reviews Immunology. 2002; 2:569-579.
2. Yu S, Cao H, Shen B and Feng J. Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget. 2015; 6:37151-37168. doi: 10.18632/oncotarget.6022.
3. Webber J, Yeung V and Clayton A. Extracellular vesicles as modulators of the cancer microenvironment. Seminars in cell & developmental biology. 2015; 40:27-34.
4. Webber J, Steadman R, Mason MD, Tabi Z and Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer research. 2010; 70:9621-9630.
5. Luga V and Wrana JL. Tumor-stroma interaction: Revealing fibroblast-secreted exosomes as potent regulators of Wntplanar cell polarity signaling in cancer metastasis. Cancer research. 2013; 73:6843-6847.
6. Chiarugi P and Cirri P. Metabolic exchanges within tumor microenvironment. Cancer letters. 2015. doi: 10.1016/j. canlet.2015.10.027
7. Gai C, Carpanetto A, Deregibus MC and Camussi G. Extracellular vesicle-mediated modulation of angiogenesis. Histology and histopathology. 2015:11708.
8. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, Garcia-Santos G, Williams C, Ararso Y, et al. Pancreatic cancer exosomes initiate premetastatic niche formation in the liver. Nature cell biology. 2015; 17:816-826.
9. Sadovska L, Eglitis J and Line A. Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer. Anticancer research. 2015; 35:6379-6390.
10. Tang MK and Wong AS. Exosomes: Emerging biomarkers and targets for ovarian cancer. Cancer letters. 2015; 367:26-33.
11. Vader P, Breakefield XO and Wood MJ. Extracellular vesicles: emerging targets for cancer therapy. Trends in molecular medicine. 2014; 20:385-393.
12. Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA and Kalluri R. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer cell. 2014; 26:707-721.
13. Raimondo F, Morosi L, Chinello C, Magni F and Pitto M. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics. 2011; 11:709-720.
14. Ung TH, Madsen HJ, Hellwinkel JE, Lencioni AM and Graner MW. Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways. Cancer science. 2014; 105:1384-1392.
15. Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, Earley JU, Hadhazy M and McNally EM. Normal myoblast fusion requires myoferlin. Development. 2005; 132:5565-5575.
16. Davis DB, Delmonte AJ, Ly CT and McNally EM. Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Human molecular genetics. 2000; 9:217-226.
17. Bernatchez PN, Sharma A, Kodaman P and Sessa WC. Myoferlin is critical for endocytosis in endothelial cells. American journal of physiology Cell physiology. 2009; 297:C484-492.
18. Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, Erdjument-Bromage H, Shah V, Gratton JP, McNally EM, Tempst P and Sessa WC. Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. The Journal of biological chemistry. 2007; 282:30745-30753.
19. Demonbreun AR, Posey AD, Heretis K, Swaggart KA, Earley JU, Pytel P and McNally EM. Myoferlin is required for insulin-like growth factor response and muscle growth. FASEB Journal. 2010; 24:1284-1295.
20. Yu C, Sharma A, Trane A, Utokaparch S, Leung C and Bernatchez P. Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo. Vascular pharmacology. 2011; 55:26-33.
21. Turtoi A, Blomme A, Bellahcene A, Gilles C, Hennequiere V, Peixoto P, Bianchi E, Noel A, De Pauw E, Lifrange E, Delvenne P and Castronovo V. Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer research. 2013; 73:5438-5448.
22. Leung C, Yu C, Lin MI, Tognon C and Bernatchez P. Expression of myoferlin in human and murine carcinoma tumors: role in membrane repair, cell proliferation, and tumorigenesis. The American journal of pathology. 2013; 182:1900-1909.
23. Turtoi A, Dumont B, Greffe Y, Blomme A, Mazzucchelli G, Delvenne P, Mutijima EN, Lifrange E, De Pauw E and Castronovo V. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. Journal of proteome research. 2011; 10:3160-3182.
24. Turtoi A, Musmeci D, Wang Y, Dumont B, Somja J, Bevilacqua G, De Pauw E, Delvenne P and Castronovo V. Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. Journal of proteome research. 2011; 10:4302-4313.
25. Wang WS, Liu XH, Liu LX, Lou WH, Jin DY, Yang PY and Wang XL. iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. Journal of proteomics. 2013; 91:453-465.
26. Li R, Ackerman WEt, Mihai C, Volakis LI, Ghadiali S and Kniss DA. Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion. PloS one. 2012; 7:e39766.
27. Volakis LI, Li R, Ackerman WEt, Mihai C, Bechel M, Summerfield TL, Ahn CS, Powell HM, Zielinski R, Rosol TJ, Ghadiali SN and Kniss DA. Loss of myoferlin redirects breast cancer cell motility towards collective migration. PloS one. 2014; 9:e86110.
28. Fahmy K, Gonzalez A, Arafa M, Peixoto P, Bellahcene A, Turtoi A, Delvenne P, Thiry M, Castronovo V and Peulen O. Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer. International journal of cancer. 2016; 138:652-663.
29. Colombo M, Raposo G and Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annual review of cell and developmental biology. 2014; 30:255-289.
30. Eisenberg MC, Kim Y, Li R, Ackerman WE, Kniss DA and Friedman A. Mechanistic modeling of the effects of myoferlin on tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108:20078-20083.
31. Forterre A, Jalabert A, Berger E, Baudet M, Chikh K, Errazuriz E, De Larichaudy J, Chanon S, Weiss-Gayet M, Hesse AM, Record M, Geloen A, Lefai E, Vidal H, Coute Y and Rome S. Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross talk? PloS one. 2014; 9:e84153.
32. Steffan JJ, Dykes SS, Coleman DT, Adams LK, Rogers D, Carroll JL, Williams BJ and Cardelli JA. Supporting a role for the GTPase Rab7 in prostate cancer progression. PloS one. 2014; 9:e87882.
33. Alonso-Curbelo D, Riveiro-Falkenbach E, Perez-Guijarro E, Cifdaloz M, Karras P, Osterloh L, Megias D, Canon E, Calvo TG, Olmeda D, Gomez-Lopez G, Grana O, Sanchez-Arevalo Lobo VJ, Pisano DG, Wang HW, Ortiz-Romero P, et al. RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer cell. 2014; 26:61-76.
34. Nakano T, Shimizu K, Kawashima O, Kamiyoshihara M, Kakegawa S, Sugano M, Ibe T, Nagashima T, Kaira K, Sunaga N, Ohtaki Y, Atsumi J and Takeyoshi I. Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: gene expression associated with metastatic potential in human lung cancer. Oncology reports. 2012; 28:1727-1735.
35. Redpath GM, Sophocleous RA, Turnbull L, Whitchurch CB and Cooper ST. Ferlins show tissue-specific expression and segregate as plasma membrane/late endosomal or trans-Golgi/recycling ferlins. Traffic. 2016; 17:245-66.
36. Seubert B, Cui H, Simonavicius N, Honert K, Schafer S, Reuning U, Heikenwalder M, Mari B and Kruger A. Tetraspanin CD63 acts as a pro-metastatic factor via betacatenin stabilization. International journal of cancer. 2015; 136:2304-2315.
37. Huang CI, Kohno N, Ogawa E, Adachi M, Taki T and Miyake M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. The American journal of pathology. 1998; 153:973-983.
38. Bogdan AR, Miyazawa M, Hashimoto K and Tsuji Y. Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease. Trends in biochemical sciences. 2016; 41:274-86.
39. Werner S, Krause F, Rolny V, Strobl M, Morgenstern D, Datz C, Chen H and Brenner H. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting. Clinical cancer research. 2015.
40. Wang SL, Cao S, Wu R, Chi F, Tang MY, Jin XY and Chen XD. Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer. Future oncology. 2015; 11:2905-2910.
41. Alkhateeb AA, Leitzel K, Ali SM, Campbell-Baird C, Evans M, Fuchs EM, Kostler WJ, Lipton A and Connor J. Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PloS one. 2012; 7:e51379.
42. Chekhun VF, Lukyanova NY, Burlaka CA, Bezdenezhnykh NA, Shpyleva SI, Tryndyak VP, Beland FA and Pogribny IP. Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin. International journal of oncology. 2013; 43:1481-1486.
43. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and Wrana JL. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012; 151:1542-1556.
44. Tadokoro H, Umezu T, Ohyashiki K, Hirano T and Ohyashiki JH. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. The Journal of biological chemistry. 2013; 288:34343-34351.
45. Zhang L, Wu X, Luo C, Chen X, Yang L, Tao J and Shi J. The 786-0 renal cancer cell-derived exosomes promote angiogenesis by downregulating the expression of hepatocyte cell adhesion molecule. Molecular medicine reports. 2013; 8:272-276.
46. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R and Kohn EC. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis. 2012; 15:33-45.
47. Bovy N, Blomme B, Freres P, Dederen S, Nivelles O, Lion M, Carnet O, Martial JA, Noel A, Thiry M, Jerusalem G, Josse C, Bours V, Tabruyn SP and Struman I. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. 2015; 6:10253-10266. doi: 10.18632/oncotarget.3520.
48. Yoshida Y, Emi N and Hamada H. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochemical and biophysical research communications. 1997; 232:379-382.
49. Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics: MCP. 2014; 13 :2513-2526.
50. Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ and von Mering C. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic acids research. 2015; 43:D447-452.
51. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P and Cardona A. Fiji: an open-source platform for biological-image analysis. Nature methods. 2012; 9:676-682.